+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

Extractables and Leachables Testing Services Market, 2018-2028 - Product Thumbnail Image

Extractables and Leachables Testing Services Market, 2018-2028

  • Report
  • September 2018
  • 200 Pages
  • Global
From
Tofersen Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Tofersen Emerging Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
From
Idiopathic Pulmonary Fibrosis: Competitive Landscape to 2026 - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis: Competitive Landscape to 2026

  • Report
  • March 2019
  • 47 Pages
  • Global
From
Arzerra - Product Thumbnail Image

Arzerra

  • Report
  • January 2019
  • 18 Pages
  • Global
From
Gene Therapy Market Report and Forecast 2023-2031 - Product Thumbnail Image

Gene Therapy Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 147 Pages
  • Global
From
From
Loading Indicator